FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Tumorimmunologie (Schwerpunkt Systembiologie)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Dermatology
Lehrstuhl für Haut- und Geschlechtskrankheiten
Overview
Publications
(158)
Research Grants
(15)
Project Types
Toggle all
Third Party Funds Group - Overall project
Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third Party Funds Group - Sub project
Third party funded individual grant
Third party funded individual grant
Internally funded project
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project
Non-FAU Project
Status
All
Upcoming
Ongoing
Finished
Project year
From
To
Filters (inactive)
ProDia - Protease Aktivität in Plasma-Vesikeln für die prädiktive Diagnostik von Tumorerkrankungen (DE-ProDia Medical Valley-Award)
Nov. 1, 2023 - April 30, 2026
E034: How neural stem cells shape their regulatory environment in the adult CNS
July 1, 2023 - March 31, 2026
E033: Deubiquitinase Otud7b in oligodendrocyte differentiation and CNS myelination
July 1, 2023 - Dec. 31, 2025
E037: CtBP1 in oligodendroglial development and myelination
Feb. 1, 2023 - Nov. 30, 2025
M5-IZFK-D043: Mechanisms controlling functionality and persistence of CD19.CAR T-cells
March 16, 2023 - Sept. 15, 2025
Systems medicine of melanoma and autoimmunity in the context of immunotherapy (MelAutim)
Oct. 1, 2019 - Jan. 31, 2025
Identification of specific tumour antigens for CAR - cell therapy against uveal melanoma by RNA sequencing and computer-assisted modelling
Jan. 1, 2022 - May 31, 2023
Gaminfection-UKE. Ein Multiebenenmodell der Lungenentzündung und seine Umsetzung als Computerspiel (Gaminfection)
April 1, 2019 - Jan. 31, 2022
Systems medicine detection and selection of universal antitumour epitopes in metastatic uveamelanoma
June 1, 2019 - June 30, 2021
A systems methodology to assess the risk of tumor relapse in melanoma by the profiling of plasma extracellular vesicles (MelEVIR)
MelEVIR
April 1, 2016 - May 31, 2020
‹
1
2
›